Kronos Worldwide (NYSE:KRO) Downgraded by StockNews.com

Kronos Worldwide (NYSE:KROGet Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday.

Several other brokerages also recently weighed in on KRO. Barclays raised their price target on shares of Kronos Worldwide from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Tuesday, March 26th. TheStreet raised shares of Kronos Worldwide from a “d+” rating to a “c-” rating in a research report on Monday, March 11th.

View Our Latest Analysis on Kronos Worldwide

Kronos Worldwide Price Performance

Shares of KRO opened at $11.29 on Friday. The company has a market capitalization of $1.30 billion, a P/E ratio of -26.26 and a beta of 1.21. The company has a quick ratio of 1.49, a current ratio of 3.01 and a debt-to-equity ratio of 0.57. The firm has a 50 day moving average of $10.51 and a 200 day moving average of $9.21. Kronos Worldwide has a twelve month low of $6.16 and a twelve month high of $12.48.

Kronos Worldwide (NYSE:KROGet Free Report) last announced its quarterly earnings results on Wednesday, March 6th. The specialty chemicals company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.02. The company had revenue of $400.10 million during the quarter, compared to the consensus estimate of $404.94 million. Kronos Worldwide had a negative net margin of 2.95% and a negative return on equity of 5.73%. As a group, equities research analysts anticipate that Kronos Worldwide will post 0.33 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. US Bancorp DE boosted its stake in shares of Kronos Worldwide by 293.2% during the 2nd quarter. US Bancorp DE now owns 4,140 shares of the specialty chemicals company’s stock worth $36,000 after acquiring an additional 3,087 shares during the last quarter. Royal Bank of Canada boosted its stake in shares of Kronos Worldwide by 214.1% during the 3rd quarter. Royal Bank of Canada now owns 5,120 shares of the specialty chemicals company’s stock worth $48,000 after acquiring an additional 3,490 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Kronos Worldwide by 25.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 5,256 shares of the specialty chemicals company’s stock worth $97,000 after acquiring an additional 1,073 shares during the last quarter. Citigroup Inc. boosted its stake in shares of Kronos Worldwide by 129.2% during the 4th quarter. Citigroup Inc. now owns 5,686 shares of the specialty chemicals company’s stock worth $53,000 after acquiring an additional 3,205 shares during the last quarter. Finally, Great West Life Assurance Co. Can boosted its stake in shares of Kronos Worldwide by 116.0% during the 1st quarter. Great West Life Assurance Co. Can now owns 6,150 shares of the specialty chemicals company’s stock worth $98,000 after acquiring an additional 3,303 shares during the last quarter. Hedge funds and other institutional investors own 15.11% of the company’s stock.

Kronos Worldwide Company Profile

(Get Free Report)

Kronos Worldwide, Inc produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company produces TiO2 in two crystalline forms, rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, and cosmetics.

See Also

Receive News & Ratings for Kronos Worldwide Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kronos Worldwide and related companies with MarketBeat.com's FREE daily email newsletter.